InterMune clinical trials
Acquired by Hoffmann-La Roche, Sep 29, 2014 · source ↗
The registry lists 15 studies whose lead sponsor is InterMune. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 3, 2009.
Before and after it joined Hoffmann-La Roche
- First submitted before InterMune became part of Hoffmann-La Roche
- 15
- First submitted after InterMune became part of Hoffmann-La Roche
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- InterMune15 studies
Something wrong with this grouping? Tell us on the Hoffmann-La Roche page.
Studies
Recruiting first, then most recently updated. Showing 15 of 15. All Hoffmann-La Roche studies →
- CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)CompletedNCT00084279Phase 2
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche
- The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT00075998Phase 3
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche
- Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal MeningitisCompletedNCT00012467Phase 2
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche
- An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPFTerminatedNCT00076635Phase 3
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche
- A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00047658Phase 2
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche
- A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving PrednisoneTerminatedNCT00052039Phase 3
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche
- An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00052052Phase 2
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche
- A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00047645Phase 3
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche
- Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant OsteopetrosisCompletedNCT00043329
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche
- Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic FibrosisCompletedNCT00043316Phase 1/2
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche
- Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or CirrhosisCompletedNCT00043303Phase 2
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche
- Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC InfectionTerminatedNCT00043355Phase 2
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche
- Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal CancerTerminatedNCT00047632Phase 3
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche
- Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic FibrosisCompletedNCT00043342Phase 1/2
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche
- Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma PatientsTerminatedNCT00057447Phase 1/2
Sponsor listed in the registry: InterMune · First submitted before InterMune became part of Hoffmann-La Roche